Sarcopenia Treatments Industry Research Report 2025

Summary


Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.

According to APO Research, The global Sarcopenia Treatments market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Sarcopenia Treatments is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sarcopenia Treatments is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sarcopenia Treatments is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Sarcopenia Treatments include Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline and Bayer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatments.
The Sarcopenia Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sarcopenia Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Sarcopenia Treatments Segment by Company

Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
Sarcopenia Treatments Segment by Type

Protein Supplement
Calcium Supplement
Other
Sarcopenia Treatments Segment by Application

Online Pharmacies
Retail Pharmacies
Sarcopenia Treatments Segment by Application

Online Pharmacies
Retail Pharmacies
Sarcopenia Treatments Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sarcopenia Treatments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sarcopenia Treatments and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sarcopenia Treatments.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sarcopenia Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Sarcopenia Treatments by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Protein Supplement
2.2.3 Calcium Supplement
2.2.4 Other
2.3 Sarcopenia Treatments by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Online Pharmacies
2.3.3 Retail Pharmacies
2.4 Assumptions and Limitations
3 Sarcopenia Treatments Breakdown Data by Type
3.1 Global Sarcopenia Treatments Historic Market Size by Type (2020-2025)
3.2 Global Sarcopenia Treatments Forecasted Market Size by Type (2026-2031)
4 Sarcopenia Treatments Breakdown Data by Application
4.1 Global Sarcopenia Treatments Historic Market Size by Application (2020-2025)
4.2 Global Sarcopenia Treatments Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Sarcopenia Treatments Market Perspective (2020-2031)
5.2 Global Sarcopenia Treatments Growth Trends by Region
5.2.1 Global Sarcopenia Treatments Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Sarcopenia Treatments Historic Market Size by Region (2020-2025)
5.2.3 Sarcopenia Treatments Forecasted Market Size by Region (2026-2031)
5.3 Sarcopenia Treatments Market Dynamics
5.3.1 Sarcopenia Treatments Industry Trends
5.3.2 Sarcopenia Treatments Market Drivers
5.3.3 Sarcopenia Treatments Market Challenges
5.3.4 Sarcopenia Treatments Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Sarcopenia Treatments Players by Revenue
6.1.1 Global Top Sarcopenia Treatments Players by Revenue (2020-2025)
6.1.2 Global Sarcopenia Treatments Revenue Market Share by Players (2020-2025)
6.2 Global Sarcopenia Treatments Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Sarcopenia Treatments Head Office and Area Served
6.4 Global Sarcopenia Treatments Players, Product Type & Application
6.5 Global Sarcopenia Treatments Manufacturers Established Date
6.6 Global Sarcopenia Treatments Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Sarcopenia Treatments Market Size (2020-2031)
7.2 North America Sarcopenia Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Sarcopenia Treatments Market Size by Country (2020-2025)
7.4 North America Sarcopenia Treatments Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Sarcopenia Treatments Market Size (2020-2031)
8.2 Europe Sarcopenia Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Sarcopenia Treatments Market Size by Country (2020-2025)
8.4 Europe Sarcopenia Treatments Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Sarcopenia Treatments Market Size (2020-2031)
9.2 Asia-Pacific Sarcopenia Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Sarcopenia Treatments Market Size by Country (2020-2025)
9.4 Asia-Pacific Sarcopenia Treatments Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Sarcopenia Treatments Market Size (2020-2031)
10.2 South America Sarcopenia Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Sarcopenia Treatments Market Size by Country (2020-2025)
10.4 South America Sarcopenia Treatments Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Sarcopenia Treatments Market Size (2020-2031)
11.2 Middle East & Africa Sarcopenia Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Sarcopenia Treatments Market Size by Country (2020-2025)
11.4 Middle East & Africa Sarcopenia Treatments Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Information
12.1.2 Abbott Laboratories Business Overview
12.1.3 Abbott Laboratories Revenue in Sarcopenia Treatments Business (2020-2025)
12.1.4 Abbott Laboratories Sarcopenia Treatments Product Portfolio
12.1.5 Abbott Laboratories Recent Developments
12.2 Nestlé
12.2.1 Nestlé Company Information
12.2.2 Nestlé Business Overview
12.2.3 Nestlé Revenue in Sarcopenia Treatments Business (2020-2025)
12.2.4 Nestlé Sarcopenia Treatments Product Portfolio
12.2.5 Nestlé Recent Developments
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Revenue in Sarcopenia Treatments Business (2020-2025)
12.3.4 Pfizer Sarcopenia Treatments Product Portfolio
12.3.5 Pfizer Recent Developments
12.4 Amway
12.4.1 Amway Company Information
12.4.2 Amway Business Overview
12.4.3 Amway Revenue in Sarcopenia Treatments Business (2020-2025)
12.4.4 Amway Sarcopenia Treatments Product Portfolio
12.4.5 Amway Recent Developments
12.5 By-health
12.5.1 By-health Company Information
12.5.2 By-health Business Overview
12.5.3 By-health Revenue in Sarcopenia Treatments Business (2020-2025)
12.5.4 By-health Sarcopenia Treatments Product Portfolio
12.5.5 By-health Recent Developments
12.6 Usana
12.6.1 Usana Company Information
12.6.2 Usana Business Overview
12.6.3 Usana Revenue in Sarcopenia Treatments Business (2020-2025)
12.6.4 Usana Sarcopenia Treatments Product Portfolio
12.6.5 Usana Recent Developments
12.7 A&Z Pharmaceutical
12.7.1 A&Z Pharmaceutical Company Information
12.7.2 A&Z Pharmaceutical Business Overview
12.7.3 A&Z Pharmaceutical Revenue in Sarcopenia Treatments Business (2020-2025)
12.7.4 A&Z Pharmaceutical Sarcopenia Treatments Product Portfolio
12.7.5 A&Z Pharmaceutical Recent Developments
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Information
12.8.2 GlaxoSmithKline Business Overview
12.8.3 GlaxoSmithKline Revenue in Sarcopenia Treatments Business (2020-2025)
12.8.4 GlaxoSmithKline Sarcopenia Treatments Product Portfolio
12.8.5 GlaxoSmithKline Recent Developments
12.9 Bayer
12.9.1 Bayer Company Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Revenue in Sarcopenia Treatments Business (2020-2025)
12.9.4 Bayer Sarcopenia Treatments Product Portfolio
12.9.5 Bayer Recent Developments
12.10 H&H
12.10.1 H&H Company Information
12.10.2 H&H Business Overview
12.10.3 H&H Revenue in Sarcopenia Treatments Business (2020-2025)
12.10.4 H&H Sarcopenia Treatments Product Portfolio
12.10.5 H&H Recent Developments
12.11 Blackmores
12.11.1 Blackmores Company Information
12.11.2 Blackmores Business Overview
12.11.3 Blackmores Revenue in Sarcopenia Treatments Business (2020-2025)
12.11.4 Blackmores Sarcopenia Treatments Product Portfolio
12.11.5 Blackmores Recent Developments
12.12 Zhendong Group
12.12.1 Zhendong Group Company Information
12.12.2 Zhendong Group Business Overview
12.12.3 Zhendong Group Revenue in Sarcopenia Treatments Business (2020-2025)
12.12.4 Zhendong Group Sarcopenia Treatments Product Portfolio
12.12.5 Zhendong Group Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings